As one of two major players in the left ventricular assist device (LVAD) market, HeartWare has been seen as an acquisition target in the past. In fact, LVAD pioneer and HeartWare competitor Thoratec tried to purchase the company once upon a time. But last week, it was Thoratec, not HeartWare, in the spotlight, when St. Jude Medical announced it plans to buy Thoratec for $3.4 billion, net of cash acquired.
Hey, check out all the engineering jobs. Post your resume today!
